Yayın:
Radiation Toxicity Concerning Salivary and Lachrymal Glands Caused by Peptide Radioligand Therapy Using a Lu-177 PSMA Inhibitor (I&T) in Patients with Metastasized Prostate Cancer: First in Human Studies

Basit öğe sayfası
dc.contributor.authorOzkan, A.
dc.contributor.authorSchuchardt, C.
dc.contributor.authorKulkarni, H.
dc.contributor.authorShahinfar, M.
dc.contributor.authorSayeg, M.
dc.contributor.authorBaum, R.
dc.date.accessioned2026-06-27T13:42:55Z
dc.date.issued2015
dc.identifier.eissn1619-7089
dc.identifier.endpageS338
dc.identifier.issn1619-7070
dc.identifier.startpageS337
dc.identifier.urihttps://hdl.handle.net/20.500.14981/54392
dc.identifier.volume42
dc.identifier.wos000363013202173
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.conference28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)
dc.relation.ispartofEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
dc.subjectRadiology, Nuclear Medicine & Medical Imaging
dc.titleRadiation Toxicity Concerning Salivary and Lachrymal Glands Caused by Peptide Radioligand Therapy Using a Lu-177 PSMA Inhibitor (I&T) in Patients with Metastasized Prostate Cancer: First in Human Studies
dc.typeMeeting Abstract
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar

Yayınlar